Literature DB >> 10969255

Mydriatics slow gastric emptying in preterm infants.

S Bonthala1, J W Sparks, K H Musgrove, C L Berseth.   

Abstract

OBJECTIVE: Preterm infants are more likely to have episodes of abdominal distention, emesis, and gastric residuals 24 hours after their first screening examination for retinopathy of prematurity (ROP) than on the day preceding the examination. Because these feeding problems reflect abnormalities in motor function, the purpose of this study was to compare antral and duodenal motor activity and gastric emptying in preterm infants before and after the instillation of mydriatics. STUDY
DESIGN: Using a low compliance continuous perfusion manometric system, we recorded antral and duodenal fasting motor activity in 11 preterm infants before and after the instillation of mydriatics for their first screening examination for ROP. Gastric emptying was compared before and after the eye examination.
RESULTS: Although the number of antral motor contractions remained relatively constant throughout the study, duodenal motor contractions decreased nearly fourfold after the instillation of mydriatics versus that seen before (P <.01). Gastric emptying was significantly delayed after the completion of the eye examination compared with that seen before the examination (P <.05).
CONCLUSION: Current doses of mydriatics inhibit duodenal motor activity and delay gastric emptying, and these gastrointestinal effects of mydriatics may underlie the feeding difficulties seen in preterm infants on the day of screening examinations for ROP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969255     DOI: 10.1067/mpd.2000.107842

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Extrinsic neural regulation of antroduodenal motor activity in preterm infants.

Authors:  Youhanna Al-Tawil; George Klee; Carol Lynn Berseth
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

2.  Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.

Authors:  Anita Mitchell; Richard W Hall; Stephen W Erickson; Charlotte Yates; Scott Lowery; Howard Hendrickson
Journal:  Curr Eye Res       Date:  2016-05-09       Impact factor: 2.424

3.  Physiologic effects of retinopathy of prematurity screening examinations.

Authors:  Anita J Mitchell; Angela Green; Debra A Jeffs; Paula K Roberson
Journal:  Adv Neonatal Care       Date:  2011-08       Impact factor: 1.968

4.  Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial.

Authors:  Caroline Hartley; Fiona Moultrie; Amy Hoskin; Gabrielle Green; Vaneesha Monk; Jennifer L Bell; Andrew R King; Miranda Buckle; Marianne van der Vaart; Deniz Gursul; Sezgi Goksan; Edmund Juszczak; Jane E Norman; Richard Rogers; Chetan Patel; Eleri Adams; Rebeccah Slater
Journal:  Lancet       Date:  2018-11-30       Impact factor: 79.321

5.  Differential effects of the retinopathy of prematurity exam on the physiology of premature infants.

Authors:  John B C Tan; Jennifer Dunbar; Andrew Hopper; Christopher G Wilson; Danilyn M Angeles
Journal:  J Perinatol       Date:  2019-02-12       Impact factor: 2.521

6.  Systematic review of mydriatics used for screening of retinopathy in premature infants.

Authors:  Lisa Jean Kremer; David M Reith; Natalie Medlicott; Roland Broadbent
Journal:  BMJ Paediatr Open       Date:  2019-05-09

7.  Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.

Authors:  Atilla Alpay; Sılay Canturk Ugurbas; Cumhur Aydemir
Journal:  BMC Pediatr       Date:  2019-11-06       Impact factor: 2.125

8.  Efficacy and safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening (MyMiROPS): study protocol for a non-inferiority crossover randomized controlled trial.

Authors:  Aikaterini K Seliniotaki; Anna-Bettina Haidich; Maria Lithoxopoulou; Helen Gika; Eleftheria Boutou; Christina Virgiliou; Martha Nikolaidou; Aristides Dokoumetzidis; Nikolaos Raikos; Elisavet Diamanti; Nikolaos Ziakas; Asimina Mataftsi
Journal:  Trials       Date:  2022-04-15       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.